Consilium Strategic Communications

Alphabetical Index | Geographical Index | Specialty Index


Consilium Strategic Communications

Consilium Strategic Communications

10 Post Office Square, #800, Boston, MA 02109

London@consilium-comms.com

www.consilium-comms.com

Biotechnology, pharmaceutical, healthcare, corporate, financial, clinical data, media relations, prescription, OTC, disease awareness, investor relations, medical devices & diagnostics, hospitals & health systems, patient advocacy, medical societies.

Employees: 31. Founded: 2013.

Agency Statement:

Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations. With offices in Europe and the US, Consilium represents international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250. Consilium's highly-skilled team has deep knowledge and expertise in providing strategic, long-term public, advocacy and investor relations advice to healthcare, biotechnology, medical technology, pharmaceutical companies and organizations, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. Consilium's offering includes precise executive, corporate, product and financial communications and media relations strategies, reputation building, patient advocacy, health education, social media strategy engagement, activation and crisis communications to deliver sustained results that inspire action and build value.

Mary-Jane Elliott, mng. partner; Amber Fennell, partner & co-founder; Chris Gardner, PhD, partner; Catherine London, US president; Jonathan Birt, Alexandra Harrison, Julia Wilson, partners; David Daley, Matthew Neal, Susan Stuart, sr. assoc. partners; Sukaina Virji, PhD, sr. assoc. partner; Jessica Hodgson, Chris Welsh, assoc. partners

Clients Include:

Advanced Medical Solutions Group Plc
Allergy Therapeutics
Alliance for Regenerative Medicine
CMR Surgical
Dementia Discovery Fund (DDF)
F-Star
Horizon
Ion Beam Applications SA (IBA)
Inivata
Innate Pharma
Iteos
Kymab
Maxcyte
Mobidiag
Orexo
Oxford Biomedica
Sensyne Health
Sequana Medical
Summit Therapeutics
Vectura